Bio Preventive Medicine Corp. (TPEX:6810)
Taiwan · Delayed Price · Currency is TWD 27.65
-0.40 (-1.43%)
At close: Jun 18, 2026
Bio Preventive Medicine Market Cap
Bio Preventive Medicine has a market cap or net worth of 1.37 billion as of June 18, 2026. Its market cap has decreased by -12.08% in one year.
Market Cap
1.37B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
27.65
Market Cap Chart
Since August 30, 2021, Bio Preventive Medicine's market cap has increased from 711.01M to 1.37B, an increase of 92.30%. That is a compound annual growth rate of 14.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.37B | 18.16% |
| Dec 31, 2025 | 1.16B | -22.00% |
| Dec 31, 2024 | 1.48B | 13.92% |
| Dec 29, 2023 | 1.30B | 8.31% |
| Dec 30, 2022 | 1.20B | -4.26% |
| Dec 30, 2021 | 1.26B | 76.61% |
| Aug 30, 2021 | 711.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Great Novel Therapeutics Biotech & Medicals | 1.72B |
| TaiRx | 1.58B |
| Anti-Microbial Savior BioteQ | 1.55B |
| Advagene Biopharma | 1.49B |
| NeoCore Technology | 1.46B |
| Andros Pharmaceuticals Co.,Ltd | 1.45B |
| GenMont Biotech Incorporation | 1.41B |
| Abnova (Taiwan) | 1.25B |